Product logins

Find logins to all Clarivate products below.


Open Surgery Instruments | Market Insights | Europe | 2022

Procedure deferrals due to the COVID-19 pandemic severely impacted the European open surgery instrument market in 2020, and the elective nature of many postponed procedures will hinder the pace of recovery to some extent. Nonetheless, following short-term disruption due to the global pandemic, the European open surgery instrument market will grow marginally throughout the remainder of the forecast period. Revenue growth will be supported by the continued uptake of innovative premium-priced products, although rising laparoscopic procedure penetration—and consequently declining open procedure volumes—will hamper market expansion. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for open surgery instruments in Europe across an 11-year period.

Related Medtech Insights Reports

Report
Peripheral Vascular Devices – Market Insights – Europe
The European PV device market will be mainly driven by the increasing availability of premium-priced products and emerging products which, supported by clinical data, will increase the penetration…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…
Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…